Acknowledgements This study was supported by grants from the Chang Gung Memorial Foundation (CMRPG-5D0111, CMRPG2F0171, CMRPG2F0172, CMRPG2F0173, CMRPG-2G0361, CMRPG-2H0161, CRRPG2H0162, CMRPG-2J0261, CMRPG-2K0091, CORPG2N0141, CORPG2P0231, and CORPG2P0191), the Ministry of Science and Technology, Taiwan (104-2320-B-182A-013, 106-2314-B-182A-064, 107-2314-B-182A-138, 108-2320-B-182A-009-MY3, 108-2314-B-182A-027, 108-2321-B-182-003 and 109-2321-B-182-001) and the Taiwanese Ministry of Health and Welfare (MOHW110-TDU-B-212-124005, MOHW111-TDU-B-212-134005, MOHW112-TDU-B-212-144005)
There is currently no official established link between GLP-1 receptor agonists and anxiety reduction, and these medications are not licensed or recommended for treating anxiety disorders
The side effects of cagrilintide are mostly mild to moderate GI symptoms like nausea, vomiting, and diarrhea
McGuire MJ, Ishii M (2016) Leptin dysfunction and Alzheimers disease: evidence from cellular, animal, and human studies
Clinicians should ask patients if they have experienced episodes of overeating with a loss of control over eating within the past 4 weeks